Abstract
With the epidemiology now well described, stroke has been uncovered as a frequent cause of neurological disease in children. Arterial ischemic stroke (AIS) is the most common type, affecting both neonates and older children. The number of associated risk factors is large with current efforts directed toward understanding the mechanisms by which they translate into a stroke. Advanced neuroimaging modalities are improving diagnostic accuracy while affording unique avenues to explore the pathophysiology of stroke and the response of the developing brain to injury. While acute interventions for pediatric stroke are in their infancy, the first randomized controlled clinical trials for the initial management and secondary prevention of pediatric stroke are poised to begin. Outcomes from childhood stroke are well defined though the accurate predictors required to guide treatment and rehabilitation remain elusive. We review the essential background, recent advances, and current clinical research issues pertaining to AIS in children.
Keywords: Pediatric stroke, arterial ischemic stroke, cerebrovascular disease, child
Current Pediatric Reviews
Title: Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Volume: 2 Issue: 4
Author(s): Adam Kirton, Michael D. Hill and Gabrielle deVeber
Affiliation:
Keywords: Pediatric stroke, arterial ischemic stroke, cerebrovascular disease, child
Abstract: With the epidemiology now well described, stroke has been uncovered as a frequent cause of neurological disease in children. Arterial ischemic stroke (AIS) is the most common type, affecting both neonates and older children. The number of associated risk factors is large with current efforts directed toward understanding the mechanisms by which they translate into a stroke. Advanced neuroimaging modalities are improving diagnostic accuracy while affording unique avenues to explore the pathophysiology of stroke and the response of the developing brain to injury. While acute interventions for pediatric stroke are in their infancy, the first randomized controlled clinical trials for the initial management and secondary prevention of pediatric stroke are poised to begin. Outcomes from childhood stroke are well defined though the accurate predictors required to guide treatment and rehabilitation remain elusive. We review the essential background, recent advances, and current clinical research issues pertaining to AIS in children.
Export Options
About this article
Cite this article as:
Kirton Adam, Hill D. Michael and deVeber Gabrielle, Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues, Current Pediatric Reviews 2006; 2 (4) . https://dx.doi.org/10.2174/157339606778699635
DOI https://dx.doi.org/10.2174/157339606778699635 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
EDITORIAL [Hot Topic: Transthyretin: A Small Protein in the Big World of Amyloidoses (Guest Editors: Adriano Martinelli and Gabriella Ortore)]
Current Medicinal Chemistry Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
Current Pharmaceutical Design Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Thyroid Disorders in Chronic Heart Failure: From Prognostic Set-up to Therapeutic Management
Endocrine, Metabolic & Immune Disorders - Drug Targets Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
Current Topics in Medicinal Chemistry Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Current Neuropharmacology Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine The HGF/c-Met Receptor System Under Pathological Conditions
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Unaddressed Issue of Optimal Antithrombotic Treatment after Coronary Artery Stenting in Patients with an Indication for Anticoagulation: Current Evidence and Suggested Practice
Vascular Disease Prevention (Discontinued) Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!
Current Cardiology Reviews Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Stem Cell Therapy for the Treatment of Acute Myocardial Infarction and Chronic Ischemic Heart Disease
Current Pharmaceutical Biotechnology Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases
Current Medicinal Chemistry Epicardial and Intramyocardial Adipose Tissue: The Enemy within
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors
Anti-Infective Agents in Medicinal Chemistry Current Concepts on Prenatal Diagnosis and Management of Fetal Tachyarrythmias
Current Cardiology Reviews What is Tobacco Smoke? Sociocultural Dimensions of the Association with Cardiovascular Risk
Current Pharmaceutical Design Monitoring Cardiac Function During Idebenone Therapy in Friedreich's Ataxia
Current Pharmaceutical Design